Back to Categories

Immunomodulatory agent Medicines in UAE

31 medicines available

About Immunomodulatory agent Medicines

This page lists all Immunomodulatory agent medicines available in UAE pharmacies. Click on any medicine name to view detailed information including uses, dosage, side effects, and availability.

Complete List of Immunomodulatory agent Medicines

Brand: ERVALI | Strength: 10 mg | Form: Hard Gelatin Capsules
Class: | Immunomodulatory agent Use: | Treatment of multiple myeloma, myelodysplastic syndromes (MDS), and certain types of lymphoma Adult dose: | Typically, 10 mg once daily, may be increased bas...
Brand: ERVALI | Strength: 15 mg | Form: Hard Gelatin Capsules
Class: | Immunomodulatory agent Use: | Treatment of multiple myeloma, myelodysplastic syndromes (MDS), and certain types of lymphoma Adult dose: | 10 mg to 25 mg once daily, depending on the speci...
Brand: ERVALI | Strength: 25 mg | Form: Hard Gelatin Capsules
Class: | Immunomodulatory agent Use: | Treatment of multiple myeloma, myelodysplastic syndromes, and certain types of lymphoma Adult dose: | Typically, 25 mg orally once daily, with adjustments ba...
Brand: ERVALI | Strength: 5 | Form: Hard Gelatin Capsules
Class: | Immunomodulatory agent Use: | Treatment of multiple myeloma, myelodysplastic syndromes, and certain types of lymphoma Adult dose: | Typically, 10 mg to 25 mg once daily, depending on the ...
Brand: LENADAIR | Strength: 10 mg | Form: Capsules
Class: | Immunomodulatory agent Use: | Treatment of multiple myeloma, myelodysplastic syndromes (MDS), and certain types of lymphoma Adult dose: | Typically, 10 mg orally once daily, may be increa...
Brand: LENADAIR | Strength: 25 mg | Form: Capsules
Class: | Immunomodulatory agent Use: | Treatment of multiple myeloma, myelodysplastic syndromes (MDS), and certain types of lymphoma Adult dose: | 25 mg orally once daily, typically on days 1-21 o...
Brand: LENADAIR | Strength: 5 mg | Form: Capsules
Class: | Immunomodulatory agent Use: | Treatment of multiple myeloma, myelodysplastic syndromes (MDS), and certain types of lymphoma Adult dose: | 10 mg to 25 mg orally once daily, depending on th...
Brand: LENAMIDE | Strength: 10 mg | Form: Hard Gelatin Capsules
Class: | Immunomodulatory agent Use: | Treatment of multiple myeloma, myelodysplastic syndromes (MDS), and certain types of lymphoma Adult dose: | 10 mg orally once daily, may be increased based o...
Brand: LENAMIDE | Strength: 25 mg | Form: Hard Gelatin Capsules
Class: | Immunomodulatory agent Use: | Treatment of multiple myeloma, myelodysplastic syndromes (MDS), and certain types of lymphoma Adult dose: | Typically, 25 mg orally once daily, with adjustme...
Brand: LENAMIDE | Strength: 5 | Form: Hard Gelatin Capsules
Class: | Immunomodulatory agent Use: | Treatment of multiple myeloma, myelodysplastic syndromes (MDS), and certain types of lymphoma Adult dose: | Typically, 10 mg to 25 mg once daily, depending o...
Brand: REVLIMID | Strength: 10 mg | Form: Capsules
Class: | Immunomodulatory agent Use: | Treatment of multiple myeloma, myelodysplastic syndromes (MDS), and certain types of lymphoma Adult dose: | 10 mg orally once daily, may be adjusted based on...
Brand: REVLIMID | Strength: 10 mg | Form: Tablets
Class: | Immunomodulatory agent Use: | Treatment of multiple myeloma, myelodysplastic syndromes (MDS), and certain types of lymphoma Adult dose: | 10 mg orally once daily; may be adjusted based on...
Brand: REVLIMID | Strength: 15 mg | Form: Capsules
Class: | Immunomodulatory agent Use: | Treatment of multiple myeloma, myelodysplastic syndromes (MDS), and certain types of lymphoma Adult dose: | 10 mg to 25 mg once daily, depending on the condi...
Brand: REVLIMID | Strength: 15 mg | Form: Tablets
Class: | Immunomodulatory agent Use: | Treatment of multiple myeloma, myelodysplastic syndromes (MDS), and certain types of lymphoma Adult dose: | 10 mg to 25 mg once daily, depending on the speci...
Brand: REVLIMID | Strength: 25 mg | Form: Capsules
Class: | Immunomodulatory agent Use: | Treatment of multiple myeloma, myelodysplastic syndromes (MDS), and certain types of lymphoma Adult dose: | 25 mg orally once daily, typically on days 1-21 o...
Brand: REVLIMID | Strength: 5 mg | Form: Capsules
Class: | Immunomodulatory agent Use: | Treatment of multiple myeloma, myelodysplastic syndromes (MDS), and certain types of lymphoma Adult dose: | 5 mg once daily, may be increased based on clinic...
Brand: SOTIRA | Strength: 10 mg | Form: Hard Gelatin Capsules
Class: | Immunomodulatory agent Use: | Treatment of multiple myeloma, myelodysplastic syndromes (MDS), and certain types of lymphoma Adult dose: | Typically 10 mg once daily, may be increased base...
Brand: SOTIRA | Strength: 15 mg | Form: Hard Gelatin Capsules
Class: | Immunomodulatory agent Use: | Treatment of multiple myeloma, myelodysplastic syndromes (MDS), and certain types of lymphoma Adult dose: | 10 mg to 25 mg once daily, depending on the speci...
Brand: SOTIRA | Strength: 25 mg | Form: Hard Gelatin Capsules
Class: | Immunomodulatory agent (IMiD) Use: | Treatment of multiple myeloma, myelodysplastic syndromes (MDS), and certain types of lymphoma Adult dose: | Typically, 25 mg orally once daily; may va...
Brand: SOTIRA | Strength: 5 | Form: Hard Gelatin Capsules
Class: | Immunomodulatory agent Use: | Treatment of multiple myeloma, myelodysplastic syndromes (MDS), and certain types of lymphoma Adult dose: | Typically 10 mg to 25 mg once daily, depending on...
Brand: PEGIHEP | Strength: 100 mcg | Form: Lyophilized powder for Injection
Class: | Peginterferon alfa-2b is classified as an antiviral and immunomodulatory agent, specifically a pegylated interferon. Use: | It is used primarily for the treatment of chronic hepatitis C infec...
Brand: PegiHep | Strength: 80 mcg | Form: Lyophilized powder for injection
Class: | Peginterferon alfa-2b is classified as an antiviral and immunomodulatory agent. Use: | Peginterferon alfa-2b is used for the treatment of chronic hepatitis C in patients with compensated liv...
Brand: IMNOVID | Strength: 1 mg | Form: Capsules
Class: | Immunomodulatory agent (IMiD) Use: | Treatment of multiple myeloma in patients who have received at least two prior therapies, including lenalidomide and a proteasome inhibitor. Adult dos...
Brand: IMNOVID | Strength: 1 mg | Form: Capsules
Class: | Immunomodulatory agent Use: | Treatment of multiple myeloma in patients who have received at least two prior therapies, including lenalidomide and a proteasome inhibitor Adult dose: | 4 m...
Brand: IMNOVID | Strength: 2 mg | Form: Capsules
Class: | Immunomodulatory agent Use: | Treatment of multiple myeloma in patients who have received at least two prior therapies, including lenalidomide and a proteasome inhibitor Adult dose: | 4 m...
Brand: IMNOVID | Strength: 2 mg | Form: Capsules
Class: | Immunomodulatory agent Use: | Treatment of multiple myeloma in patients who have received at least two prior therapies, including lenalidomide and a proteasome inhibitor Adult dose: | 4 m...
Brand: IMNOVID | Strength: 3 mg | Form: Capsules
Class: | Immunomodulatory agent Use: | Treatment of multiple myeloma in patients who have received at least two prior therapies, including lenalidomide and a proteasome inhibitor Adult dose: | 4 m...
Brand: IMNOVID | Strength: 3 mg | Form: Capsules
Class: | Immunomodulatory agent Use: | Treatment of multiple myeloma in patients who have received at least two prior therapies, including lenalidomide and a proteasome inhibitor Adult dose: | 4 m...
Brand: IMNOVID | Strength: 4 mg | Form: Capsules
Class: | Immunomodulatory agent Use: | Treatment of multiple myeloma in patients who have received at least two prior therapies, including lenalidomide and a proteasome inhibitor Adult dose: | 4 m...
Brand: IMNOVID | Strength: 4 mg | Form: Capsules
Class: | Immunomodulatory agent Use: | Treatment of multiple myeloma in patients who have received at least two prior therapies, including lenalidomide and a proteasome inhibitor Adult dose: | 4 m...
Brand: POMALYST | Strength: 4 mg | Form: Capsules
Class: | Immunomodulatory agent Use: | Treatment of multiple myeloma in patients who have received at least two prior therapies, including lenalidomide and a proteasome inhibitor, and have demonstra...
Browse All Categories Search Medicines